Literature DB >> 16322385

Evaluation of the effectiveness of midnight serum cortisol in the diagnostic procedures for Cushing's syndrome.

Giuseppe Reimondo1, Barbara Allasino, Silvia Bovio, Piero Paccotti, Alberto Angeli, Massimo Terzolo.   

Abstract

OBJECTIVE: It is presently unclear whether the accuracy of midnight serum cortisol (F24) in the diagnosis of Cushing's syndrome (CS) may be replicated under usual conditions of clinical care. The aim of the present study was to assess retrospectively the effectiveness of F24 for confirming the diagnosis in a consecutive series of 106 patients, in 78 of whom a definitive diagnosis of CS was made. DESIGN AND METHODS: We have compared the results of F24, urinary free cortisol (UFC) and the overnight 1 mg dexamethasone suppression test (DST) with the definitive clinical diagnosis. Receiver operating characteristic (ROC) analysis has been performed to define the best cutoff values, the sensitivity (Se) and the specificity (Sp) of the tests.
RESULTS: The best cutoff value for F24 was 8.3 microg/dl (Se 91.8%; Sp 96.4%). The best cutoff value for the DST was 4.0 microg/dl (Se 89.2%; Sp 90.9%). The best cutoff value for UFC was 238 microg/24 h (Se 73.2%; Sp 96.3%). The area under the curve of F24 was significantly greater than that of UFC, both in the overall series (P = 0.004) and in the subgroup of patients with mild CS (P = 0.02). The differences were analyzed by means of the two-tailed students's t-test. With the thresholds generated by the ROC analysis, UFC would have failed to achieve the correct diagnosis in a significantly higher percentage of cases than F24 (20.4% vs 7.9%; P = 0.01). The difference was analyzed by means of the chi-squared test with Yates correction.
CONCLUSIONS: The present results show that F24 has excellent effectiveness in the diagnostic procedures for CS in stressed conditions (patients studied in a hospital ward in a nonsleeping state). The test appears to be accurate also for patients with mild hypercortisolism.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16322385     DOI: 10.1530/eje.1.02042

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  8 in total

Review 1.  Dynamic testing in Cushing's syndrome.

Authors:  Blerina Kola; Ashley B Grossman
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

2.  The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.

Authors:  Lynnette K Nieman; Beverly M K Biller; James W Findling; John Newell-Price; Martin O Savage; Paul M Stewart; Victor M Montori
Journal:  J Clin Endocrinol Metab       Date:  2008-03-11       Impact factor: 5.958

3.  The diagnostic accuracy of increased late night salivary cortisol for Cushing's syndrome: a real-life prospective study.

Authors:  F Ceccato; G Marcelli; M Martino; C Concettoni; M Brugia; L Trementino; G Michetti; G Arnaldi
Journal:  J Endocrinol Invest       Date:  2018-07-09       Impact factor: 4.256

Review 4.  The diagnosis of Cushing's syndrome.

Authors:  Ty B Carroll; James W Findling
Journal:  Rev Endocr Metab Disord       Date:  2010-06       Impact factor: 6.514

5.  Pros and cons of dexamethasone suppression test for screening of subclinical Cushing's syndrome in patients with adrenal incidentalomas.

Authors:  G Reimondo; B Allasino; S Bovio; L Saba; A Ardito; A Angeli; M Terzolo
Journal:  J Endocrinol Invest       Date:  2010-07-13       Impact factor: 4.256

Review 6.  Evaluation of the hypothalamic-pituitary-adrenal axis function in childhood and adolescence.

Authors:  George P Chrousos; Tomoshige Kino; Evangelia Charmandari
Journal:  Neuroimmunomodulation       Date:  2009-06-29       Impact factor: 2.492

Review 7.  Cushing's syndrome: epidemiology and developments in disease management.

Authors:  Susmeeta T Sharma; Lynnette K Nieman; Richard A Feelders
Journal:  Clin Epidemiol       Date:  2015-04-17       Impact factor: 4.790

8.  Cushing's Syndrome in a Patient With Rathke's Cleft Cyst and ACTH Cell Hyperplasia Detected by 11C-Methionine PET Imaging-A Case Presentation.

Authors:  Karol Piotr Sagan; Elzbieta Andrysiak-Mamos; Leszek Sagan; Przemysław Nowacki; Bogdan Małkowski; Anhelli Syrenicz
Journal:  Front Endocrinol (Lausanne)       Date:  2020-07-22       Impact factor: 5.555

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.